Stents Peripheral

Peripheral stents are used to open narrow and hardening arteries that supply blood to the legs and feet.

FDA Panel Recommends Continued Use of Paclitaxel-coated Peripheral Devices
Feature | Peripheral Artery Disease (PAD) | Jeff Zagoudis, Associate Editor

August 28, 2019 — The U.S. Food and Drug Administration (FDA) released an updated MedWatch Alert this month on the ...

Home August 28, 2019
Home
News | Peripheral Artery Disease (PAD)

August 1, 2019 — Less-invasive procedures to open severely clogged leg arteries were as good at helping people survive ...

Home August 01, 2019
Home
Technology | Peripheral Artery Disease (PAD)

April 15, 2019 – Intact Vascular Inc. received U.S. Food and Drug Administration (FDA) market clearance for the Tack ...

Home April 15, 2019
Home
The Boston Scientific Eluvia self-expanding, drug-eluting peripheral stent. It outperformed the Cook Zilver stent in the IMPERIAL Trial presented at TCT 2018.
Feature | Peripheral Artery Disease (PAD) | Dave Fornell, Editor

In recent years, there has been a lot of focus by vendors on developing better stenting technologies to treat peripheral ...

Home January 30, 2019
Home
The safety of paclitaxel-eluting stents and drug-coated balloons was called into question in a recent study that showed higher mortality rates after two years. The Cook Zilver PTX paclitaxel-eluting peripheral stent is among the devices included in that study.
Feature | Peripheral Artery Disease (PAD) | Dave Fornell, Editor

The anti-proliferative drug paclitaxel has been used as a coating on coronary stents to prevent restenosis since 2003 ...

Home January 25, 2019
Home
News | Peripheral Artery Disease (PAD)

January 17, 2019 — The U.S. Food and Drug Administration (FDA) issued a letter Jan. 17, 2019, to healthcare providers ...

Home January 17, 2019
Home
Videos

Professor Ian Meredith, MBBS, Ph.D., global chief medical officer and executive vice president, Boston Scientific ...

Home October 11, 2018
Home
Technology | Stents Peripheral

October 5, 2018 — Veryan Medical Ltd has received Premarket Approval (PMA) for the BioMimics 3D Vascular Stent System ...

Home October 05, 2018
Home
News | Peripheral Artery Disease (PAD)

May 15, 2018 — The Society for Cardiovascular Angiography and Interventions (SCAI) has released new guidelines to ...

Home May 15, 2018
Home
News | Stents Peripheral

April 27, 2018 — Intact Vascular Inc. recently closed a Series C financing totaling $20 million. This financing is ...

Home April 27, 2018
Home
News | Cardiovascular Clinical Studies

February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS-2 ...

Home February 01, 2018
Home
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.
Feature | Cath Lab

September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials ...

Home September 14, 2017
Home
News | Stents Peripheral

July 26, 2017 — Intact Vascular Inc. recently announced that its Tack Optimized Balloon Angioplasty II Below the Knee ...

Home July 26, 2017
Home
News | Peripheral Artery Disease (PAD)

July 17, 2017 — LimFlow SA announced enrollment of the first patient in the U.S. feasibility study of the LimFlow ...

Home July 17, 2017
Home
News | Stents Peripheral

July 14, 2017 — Intact Vascular Inc. announced the U.S. Food and Drug Administration (FDA) approved an Investigational ...

Home July 14, 2017
Home
Subscribe Now